WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
228,700
206,900
150,700
143,600
95,600
Depreciation & amortization
104,300
104,400
96,700
90,700
89,900
Deferred income taxes
-
900
41,700
21,500
-8,900
Stock based compensation
19,100
15,100
16,100
19,500
29,600
Change in working capital
-30,600
-28,300
-41,400
-58,700
-10,800
Accounts receivable
-
-43,800
-39,700
-23,300
-14,100
Inventory
-
-7,000
-3,600
-21,200
-11,400
Accounts Payable
-
400
12,600
6,100
17,200
Other working capital
200,700
288,600
263,300
219,400
212,400
Other non-cash items
3,900
1,600
700
17,500
122,500
Net cash provided by operating activites
314,300
288,600
263,300
219,400
212,400
Cash flows from investing activities
Investments in property, plant and equipment
-113,600
-104,700
-130,800
-170,200
-131,600
Acquisitions, net
-18,900
0
-6,000
-
-
Purchases of investments
-
-
-
-8,400
-
Sales/Maturities of investments
-
-
-
0
-
Other investing activites
1,600
3,900
3,200
2,800
2,100
Net cash used for investing activites
-130,900
-100,800
-133,600
-175,800
-129,500
Cash flows from financing activities
Debt repayment
-28,100
-100
-34,900
-69,800
-98,800
Common stock issued
5,100
4,900
4,400
3,800
3,200
Common stock repurchased
-87,500
-75,200
-78,200
-55,900
-5,600
Dividends Paid
-43,600
-42,100
-39,100
-35,800
-32,400
Other financing activites
-
-
-700
17,900
8,000
Net cash used privided by (used for) financing activities
-85,500
-80,700
-109,000
-113,900
-41,500
Net change in cash
101,200
101,500
32,900
-71,600
19,300
Cash at beginning of period
225,500
235,900
203,000
274,600
255,300
Cash at end of period
323,400
337,400
235,900
203,000
274,600
Free Cash Flow
Operating Cash Flow
314,300
288,600
263,300
219,400
212,400
Capital Expenditure
-113,600
-104,700
-130,800
-170,200
-131,600
Free Cash Flow
200,700
288,600
263,300
219,400
212,400